Reference
Reference TypeDual
TitleHigh-throughput discovery of Chagas Disease antigens and their linear B-cell epitopes using high-density peptide arrays
Submission TitleTowards high-throughput immunomics for infectious diseases: use of next-generation peptide microarrays for rapid discovery and mapping of antigenic determinants.
AuthorsSantiago J Carmona; Morten Nielsen; Claus Schafer-Nielsen; Juan Mucci; Jaime Altcheh; Virginia Balouz; Valeria Tekiel; Alberto C Frasch; Oscar Campetella; Carlos A Buscaglia; Fernan Aguero
Submission AuthorsSantiago J Carmona; Morten Nielsen; Claus Schafer-Nielsen; Juan Mucci; Jaime Altcheh; Virginia Balouz; Valeria Tekiel; Alberto C Frasch; Oscar Campetella; Carlos A Buscaglia; Fernán Agüero
AffiliationsInstituto de Investigaciones Biotecnologicas – Instituto Tecnologico de Chascomus, Universidad de San Martin –CONICET
Submission AffiliationsInstituto de Investigaciones Biotecnologicas, Universidad de San Martin, Argentina; Schafer-N ApS, Denmark; Hospital de Niños Dr. Ricardo Gutierrez, Argentina; fernan@iib.unsam.edu.ar.
JournalMol Cell Proteomics
SubmitterSantiago J Carmona
Year2014
Submission Date2015
AbstractPeptides were synthesized in situ on microarray slides, spanning the complete length of 457 Trypanosoma cruzi proteins with fully overlapped 15mers (1 residue shift). Antibody-binding was assayed using antibodies purified from infected patients and healthy donors.
Submission AbstractComplete characterization of antibody specificities associated to natural infections is expected to provide a rich source of serologic biomarkers with potential applications in molecular diagnosis, follow-up of chemotherapeutic treatments, and prioritization of targets for vaccine development. Here, we developed a highly-multiplexed platform based on next-generation high-density peptide microarrays to map these specificities in Chagas Disease, an exemplar of a human infectious disease caused by the protozoan Trypanosoma cruzi. We designed a high-density peptide microarray containing more than 175,000 overlapping 15mer peptides derived from T. cruzi proteins. Peptides were synthesized in situ on microarray slides, spanning the complete length of 457 parasite proteins with fully overlapped 15mers (1 residue shift). Screening of these slides with antibodies purified from infected patients and healthy donors demonstrated both a high technical reproducibility as well as epitope mapping consistency when compared with earlier low-throughput technologies. Using a conservative signal threshold to classify positive (reactive) peptides we identified 2,031 disease-specific peptides and 97 novel parasite antigens, effectively doubling the number of known antigens and providing a tenfold increase in the number of fine mapped antigenic determinants for this disease. Finally, further analysis of the chip data showed that optimizing the amount of sequence overlap of displayed peptides can increase the protein space covered in a single chip by at least ~3 fold without sacrificing sensitivity. In conclusion, we show the power of high-density peptide chips for the discovery of pathogen-specific linear B-cell epitopes from clinical samples, thus setting the stage for high-throughput biomarker discovery screenings and proteome-wide studies of immune responses against pathogens.
Curation Last Updated2023-08-18 21:58:02
Epitope
Epitope ID320649
Chemical TypeLinear peptide
Linear SequenceKLKLCVRLLTDALSK
Source Molecule Namemyosin heavy chain
Source OrganismTrypanosoma cruzi strain CL Brener
Starting Position3504
Ending Position3518
Epitope Reference Details
Epitope Structure DefinesEpitope containing region/antigenic site
Epitope NameTc00.1047053506491.20_3504
Location of Data in ReferenceAuthor submitted
Immunization
Host OrganismHomo sapiens (human)
Host Details
Host GeolocationArgentina
1st In Vivo Process
In Vivo Process TypeOccurrence of infectious disease
Disease StateChagas disease
Disease StageChronic;OGMS:0000064
1st Immunogen
Epitope RelationTaxonomic Parent
Object TypeOrganism
OrganismTrypanosoma cruzi
B Cell Assay
Qualitative MeasurementNegative
Method/TechniqueHigh throughput multiplexed assay
Measurement ofantibody binding
Assayed Antibody
Assayed Antibody Source MaterialPurified Immunoglobulin
Assayed Antibody Immunoglobulin DomainEntire Antibody
Assayed Antibody Purification StatusPolyclonal
Assayed Antibody Heavy Chain TypeIgG
Antigen
Epitope RelationEpitope
Chemical TypeLinear peptide
Linear SequenceKLKLCVRLLTDALSK
Source Molecule Namemyosin heavy chain
Source OrganismTrypanosoma cruzi strain CL Brener
Starting Position3504
Ending Position3518
Assay Reference Details
Location of Assay Data in ReferenceAuthor submitted